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Changes in synaptic strength mediated by ionotropic gluta-
mate N-methyl-D-asparate (NMDA) receptors is generally con-
sidered to be themolecularmechanismunderlyingmemory and
learning. NMDA receptors themselves are subject to regulation
through signaling pathways that are activated by G-protein-
coupled receptors (GPCRs). In this study we investigate the
ability of NMDA receptors to regulate the signaling of GPCRs
by focusing on the Gq/11-coupled M3-muscarinic receptor
expressed endogenously in mouse cerebellar granule neu-
rons. We show that NMDA receptor activation results in the
phosphorylation and desensitization of M3-muscarinic recep-
tors through a mechanism dependent on NMDA-mediated cal-
cium influx and the activity of calcium-calmodulin-dependent
protein kinase II. Our study reveals a complex pattern of regu-
lation where GPCRs (M3-muscarinic) andNMDA receptors can
feedback on each other in a process that is likely to influence the
threshold value of signaling networks involved in synaptic
plasticity.
Glutamate neurotransmission mediated through the iono-
tropic N-methyl-D-asparate (NMDA),3 -amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA), and kainate recep-
tors is the primary excitatory stimulus in the central nervous
system (1). NMDA and AMPA receptors are found co-ex-
pressed at the post-synaptic membrane of glutaminergic syn-
apses. AMPA receptors, permeable to sodium and potassium
ions, open in response to glutamate generating rapid excitatory
post-synaptic potentials. NMDA receptors allow for the influx
of extracellular calcium into the post-synaptic cell in response
to glutamate and a concomitant depolarization that relieves the
magnesium block of channel conductance. Through the tem-
poral and spatial summation of excitatory post-synaptic poten-
tials and glutamate release, NMDA receptors can contribute
significantly to post-synaptic membrane depolarization.
In addition, NMDA receptors can influence post-synaptic
activity in amore subtlemanor by allowing for changes in intra-
cellular calcium concentrations that initiate calcium-depend-
ent signaling cascades (2, 3). Prominent among these signaling
cascades is the regulation of protein phosphorylation via both
calcium/calmodulin-dependent kinase II (CamKII) (3, 4) and
the protein phosphatases protein phosphatase 1 and cal-
cineurin (5).
These signaling events are among a number of mechanisms
that are proposed to regulate NMDA-mediated changes in syn-
aptic strength (6). Synaptic plasticity of this type is frequently
measured as long term potentiation (LTP) and depression
(LTD) and is widely regarded as a molecular mechanism that
contributes to memory and learning (7, 8). It is now clear that
the clustering of signaling molecules around NMDA and
AMPA receptors at specialized post-synaptic sites coordinate
signaling pathways involved in the adaptation of synaptic activ-
ity (3, 9). Among these signaling molecules are members of the
G-protein-coupled receptor (GPCR) family (6) where receptors
such as metabotropic glutamate (10, 11), adrenergic (12–14),
pituitary adenylyl cyclase-activating polypeptide receptor 1
(15), andmuscarinic (16) receptors are found closely associated
withNMDAreceptors. TheseGPCRs regulateNMDA function
through a variety of signaling pathways such as the well estab-
lished second messenger-regulated pathways of calciummobi-
lization, protein kinase C (17, 18) and cAMP-dependent pro-
tein kinase (19) and additionally via nonreceptor tyrosine
kinases Pyk2 (20) and Src (21) through activation of the mito-
gen-activated protein kinase cascade (22) and control of gene
transcription (23). There is, therefore, an extensive range of
mechanisms by which GPCRs can influence NMDA receptor
function in neurons.
In the current study we investigate further the relationship
between NMDA receptors and GPCRs by focusing on the
M3-muscarinic receptor endogenously expressed in cerebellar
granule (CG) neurons. Previous studies have determined that
muscarinic receptors regulate both NMDA receptor function
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and contribute to LTP and LTD (16, 24–27). Here we demon-
strate that the NMDA receptor-mediated activation of CamKII
results in the phosphorylation of the M3-muscarinic receptor
and subsequent uncoupling of the receptor from the Gq/11/
phosphoinositide pathway. Our study demonstrates that there
is a complex reciprocal relationship between GPCRs and
NMDA receptors where each is able to regulate the activity of
the other in a process that is likely to be essential in establishing
the threshold activities that contribute to synaptic plasticity.
EXPERIMENTAL PROCEDURES
Primary Cell Culture—Mouse CG neurons were cultured as
described previously (28). In brief, cerebella from 7–8-day-old
Balb/c pups weremechanically and enzymatically (trypsin) dis-
sociated. The cells were subsequently plated on poly-L-lysine-
coated 6-well plates (Nunclon) or on round glass coverslips
(25-mm diameter) at a cell density of 0.25  106 cells/cm2, in
basal medium Eagle (Invitrogen) supplemented with 20 mM
KCl, penicillin/streptomycin, 10% fetal calf serum. Cytosine
arabionoside (10 M) was added 48 h after plating to prevent
glial cell proliferation. The cultures were incubated at 37 °C in a
humidified atmosphere with 5% CO2 and used after 7–8 days.
The experiments were performed in CSS-25 buffer (120 mM
NaCl, 1.8mMCaCl2, 15mM glucose, 25mMKCl, 25mMHEPES,
pH 7.4) or in a modified CSS-25 buffer as indicated).
For transfection of siRNA duplexes CG neurons cultured for
5 days were transfected with either siRNA duplexes specific for
CamKII- (purchased as verified siRNA from Santa Cruz Bio-
technology, Inc.) or scrambled siRNA control. CG neurons
were transfected with 80 pmol of scrambled siRNA or 80 pmol
of specific siRNA using 5 l of FuGENE HD transfection rea-
gent (Roche Applied Science) per transfection. The cells were
used for phosphorylation experiments 48 h post-transfection.
M3-muscarinic Receptor Phosphorylation—In vivo [32P]ortho-
phosphate labeling, receptor solubilization, and immunopre-
cipitationwere conducted as described previously (29). In brief,
CG neurons in 6-well plates were washed and incubated for 2 h
in CSS-25 buffer (1ml) containing 100Ci/ml [32P]orthophos-
phate (GE Healthcare). The cells were then stimulated with
methacholine, glutamate, NMDA, AMPA, or kainic acid at a
final concentration of 100M for 5min unless otherwise stated.
Where appropriate, antagonists or other compounds were
added before the addition of agonists. The cells were then lysed
in lysis buffer (10 mM EDTA, 500 mM NaCl, 1% Nonidet P-40,
0.5%deoxycholate, 10mMTris, pH7.4), and theM3-muscarinic
receptor was immunoprecipitated using an in house anti-
mouse M3 receptor polyclonal antibody (29). Immunoprecipi-
tated proteins were resolved by 8% SDS-PAGE and visualized
by autoradiography or using a STORM phosphor-imager (GE
Healthcare). To control for equal receptor loading, immuno-
precipitated proteins resolved by SDS-PAGE were transferred
to nitrocellulose. The membranes were then exposed before
being used inWestern blots with M3-muscarinic receptor spe-
cific monoclonal antibodies (see Figs. 1A and 3A). Quantifica-
tion of the phosphorylation status of the receptor was deter-
mined by analysis using the ImageQuant and AlphaEase
softwares.
Single Cell Imaging of Calcium and Phosphoinositide
Responses—Experiments examining changes in free intracellu-
lar Ca2 were conducted on CG neurons cultured on cover-
slips. The cells were loaded with the Ca2 indicator fura-2 AM
(2 M, 30 min) (Molecular Probes) in CSS-25 at 37 °C and
mounted on to a Zeiss Axiovert 200 inverted epifluorescence
microscope fitted with a perfusion chamber (flow rate at 3
ml/min). The cells were excited at 340 and 380 nm at a sample
rate of 0.67Hz bymeans of an excitation filterwheel. Sequential
fluorescent image pairs were collected atwavelengths510 nm
via a cooled CCD camera (ORCA-ER, Hamamatsu) and con-
verted to pseudo color images after background subtraction.
Free intracellular Ca2 signal was expressed as 340/380 ratio of
fluorescence. Approximately 10–15 cells were analyzed in each
experiment, and the mean values from different cultures were
averaged.
For experiments involving analysis of phosphoinositide sig-
naling, the translocation of eGFP-PHPLC1 from the plasma
membrane to the cytosol was conducted as described previ-
ously (30, 31). Plasmid DNA carrying the eGFP-PHPLC1 con-
struct was transfected into CG neurons via the calcium-phos-
phate precipitation method. Briefly, 1 day after preparation of
CG neurons, 3g of DNA/well in a volume of 10l of H2Owas
added to 85l of HEPES-buffered saline (137mMNaCl, 5.6mM
glucose, 50 mM KCl, 0.7 mM Na2HPO4, 21 mM HEPES, pH 7.1)
and to 5l 2.5 M CaCl2. After 20min, the solution was added to
the cells. The following day, the medium was replaced with
fresh medium, and the cells were cultured for a further 6–7
days. The coverslips were then mounted on to the microscope,
and images of eGFP were captured at a rate of 1 Hz. Phosphoi-
nositide responses were measured as the relative change in flu-
orescence intensity in the cytosol. The data are expressed as a
self-ratio (F/F0) resulting from subtraction of background fluo-
rescence followed by dividing the fluorescence intensity at a
given time by the initial fluorescence within each region of
interest. Where NMDAwas used to stimulate CG neurons, the
cells were perfused with Mg2-free buffer before the addition
of NMDA.
NMDA Desensitization of the M3-muscarinic Receptor Phos-
phoinositide Response—CGneurons expressing eGFP-PHPLC1
were perfused with CSS-25 containing a maximal concentra-
tion ofmethacholine (100M) for 2min. This generated a phos-
phoinositide response that was termed S1 and served as an
internal control. Methacholine was then removed, and a lag
time of 12minwas allowed for the cells to recover. NMDA (100
M) was then applied for 5 min, followed by a wash-out period
of 2 min. The cells were then stimulated with a second applica-
tion of methacholine, and the resulting phosphoinositide
response was termed S2. Desensitization of the M3-muscarinic
receptor response was determined as the difference in the
amplitude between the S1 and S2 responses.
Radioligand Binding and Internalization Assays—CG neu-
rons cultured in 6-well plates were incubated with CSS-25 con-
taining NMDA (100M) and/or methacholine (100M) for the
indicated times. The cells were then washed three times with
ice-cold CSS-25 and incubated with CSS-25 containing a satu-
rating concentration of the muscarinic receptor antagonist
[3H]N-methylscopolamine (0.5 nM) for 4 h at 4 °C. The cells
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FIGURE 1.Activation of NMDA receptors induces phosphorylation ofM3-muscarinic receptor. A, representative autoradiograph of M3-muscarinic recep-
tors immunoprecipitated from [32P]orthophosphate labeled CG neurons prepared from wild type (WT) mice or M3-muscarinic receptor knock-out (KO) mice.
The CG neuronswere stimulated for 5minwith either; vehicle, methacholine (100M), or NMDA (100M). In these experiments immunoprecipitated proteins
resolved by SDS-PAGE were transferred to nitrocellulose, and after exposure for phosphorylation the nitrocellulose was probed using a receptor-specific
monoclonal antibody. This served as a loading control for the M3-muscarinic receptor. B, phosphorylation of the M3-muscarinic receptor in response to
methacholine (100 M), with or without atropine (10 M), and to glutamate (100 M) or NMDA (100 M). C, phosphorylation of the M3-muscarinic receptor in
CG neurons stimulated with the ionotropic glutamate receptor agonists NMDA, AMPA, and kainic acid (all at 100 M). D, effect of the NMDA receptor
antagonistsMK-801 (5M, 10min) and AP-5 (20M, 10min). E, time course ofM3-muscarinic receptor phosphorylation following stimulationwith NMDA (100
M). Graphs represent quantification of phosphorylation (means S.D.) fromat least three replicates, normalized to the basal phosphorylation of the receptor
in control cells with no stimulation. *, significant difference between basal and stimulated samples (p 0.01).
NMDA-mediated Regulation ofM3-muscarinic Receptors
JUNE 19, 2009•VOLUME 284•NUMBER 25 JOURNAL OF BIOLOGICAL CHEMISTRY 17149
were then washed three times with
ice-cold CSS-25 and solubilized by
the addition of lysis buffer (200M).
Receptor expression was deter-
mined by liquid scintillation count-
ing. Nonspecific binding was deter-
mined by the inclusion of 10 M
atropine.
In Vitro Phosphorylation of GST-
Third Intracellular Loop Fusion
Protein—GST fusion constructs
containing the full mouse third
intracellular loopR252 toT491 (GST-
3iloop) or GST alone were
expressed in Escherichia coli BL21
(DE3) IRL bacteria and purified as
described previously (32). 5 g of
protein was incubated with 200 ng
of CaM kinase II (New England Bio-
labs) in assay buffer (10 mM HEPES,
pH 7.4, 2.5mM-glycerophosphate,
0.5 mM CaCl2, 5 mM MgCl2, 1 mM
dithiothreitol, 0.03 mg/ml calmod-
ulin (Calbiochem)) containing 50
M ATP and 10 Ci of [-32P]ATP.
The reactions were incubated for 30
min at 37 °C and stopped by the
addition of an equal volume of 2
SDS-PAGE sample buffer. The
reactions were separated by SDS-
PAGE on 12% gels, dried, and
exposed to autoradiography film.
For mass spectrometric experi-
ments, the reactions were carried
out in assay buffer containing 1 mM
ATP. After separation by SDS-
PAGE, the proteins were trans-
ferred to nitrocellulose, and the pro-
tein bands were revealed by staining
with Ponceau S (Sigma). The pro-
tein bands were excised from the
membrane and blocked with 0.5%
polyvinylpyrrolidone in 0.6% acetic
acid for 30 min at 37 °C before
digestion with trypsin (1 g) in 50
mM ammonium bicarbonate, over-
night at 37 °C. Tryptic peptides
were collected, dried in a rotary
evaporator, and resuspended in
50% acetonitrile, 0.1% formic acid.
Enrichment of phosphopeptides
was carried out using titanium
dioxide contained in a MonoTip
(GL Sciences Inc) according to the
manufacturer’s instructions, and
the phosphopeptides were eluted in a solution of 5% ammo-
nium hydroxide containing 20% acetonitrile. Where indi-
cated, the enriched phosphopeptides were dried and resus-
pended in 10 mM Tris, pH 7.4, 10 mmCaCl2 and subjected to
further proteolytic digestion by the addition of 1 g of chy-
motrypsin (Roche Applied Science) for 2 h at 25 °C.
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MALDI-TOF Mass Spectrometry—Samples resulting from
trypsin or chymotrypsin digestion were acidified with formic
acid and mixed 1:1 with a solution containing 10 mg/ml of
2,5-dihydroxybenzoic acid (Sigma) in 50% acetonitrile, 1%
phosphoric acid. An aliquot of the resulting sample (0.5l) was
spotted onto a stainless steel target plate.
Analysis of peptide digests was carried out using a Voyager
DE-STR MALDI-TOF mass spectrometer (Applied Biosys-
tems,Warrington, UK) in positive ion reflectronmode over the
m/z range 800–7000.
LC-MS/MS—LC-MS/MS was carried out upon each sample
using a 4000 Q-Trap mass spectrometer (Applied Biosystems,
Warrington, UK). Peptides resulting from proteolytic digestion
were loaded at high flow rate onto a reverse phase trapping
column (0.3mm inner diameter 1mm), containing 5MC18
300 Å Acclaim PepMap media (Dionex) and eluted through a
reverse phase capillary column (75 m inner diameter  150
mm) containing Jupiter Proteo 4M 90Åmedia (Phenomenex,
UK) that was self-packed using a high pressure packing device
(Proxeon Biosystems, Odense, Denmark). The output from the
column was sprayed directly into the nanospray ion source of
the 4000 Q-Trap mass spectrometer. The analysis was carried
out in positive ion mode using data-dependent switching.
Fragment ion spectra generated by LC-MS/MS were
searched using the MASCOT search tool (Matrix Science Ltd.,
London, UK) against an updated copy of the SwissProt protein
data base using appropriate parameters. The criteria for protein
identification were based on the manufacturer’s definitions
(Matrix Science Ltd.) (33) Candidate peptides with probability-
based Mowse scores exceeding threshold (p 0.05), thus indi-
cating a significant or extensive homology, were referred to as
“hits.” Protein scores were derived from peptide ion scores as a
non-probability basis for ranking proteins.
For the phosphopeptides elucidated byMASCOT, individual
MS/MS spectrawere interrogatedmanually to validate both the
peptide identity and position of assignment. In each case it was
clear as to the identity of the peptide (and that the peptide was
indeed phosphorylated), but for some MS/MS spectra it was not
possible to validate the MASCOT assignment of the residue
position for phosphorylation, because of low abundance of the
required fragment ions. In these cases (because the sample
amount was not limiting), the samples were repeated using
multiple reaction monitoring inclusion lists comprising ion
pairs consisting of the precursor ion [M2H]2 and that of the
neutral ion loss [M2H-H3PO4]2, such that the MS/MS data
were obtained over a longer time period (5.86 s), which resulted
in significantly improved data quality. This allowed unambigu-
ous assignment of the position of phosphorylation.
Data Analysis—The statistic used was S.D. of at least three
determinations, and significance was determined using Stu-
dent’s t test or one-way analysis of variance for multiple com-
parisons. Significance was accepted when p 0.05.
RESULTS
NMDAReceptorsMediateM3-muscarinic Receptor Phospho-
rylation in CG Neurons—The phosphorylation status of the
M3-muscarinic receptor can be monitored by prelabeling cells
with [32P]orthophosphate followed by solubilization of the
receptor and immunoprecipitation with receptor specific anti-
bodies (34, 35). Experiments of this type have previously dem-
onstrated that the M3-muscarinic receptor endogenously
expressed in mouse CG neurons is phosphorylated upon stim-
ulation with the muscarinic receptor agonist methacholine
(29). In the current study we demonstrate that stimulation of
glutamate receptors usingNMDA resulted in an increase in the
phosphorylation state of the M3 muscarinic receptor (Fig. 1A).
In these experiments the phosphorylated M3-muscarinic
receptor appears as a band running at just less than 100 kDa.
Western blots of the nitrocellulose membrane containing the
radiolabeled phosphorylated receptor demonstrated that equal
amounts of receptor are immunoprecipitated under various
stimulation conditions (Fig. 1A). Importantly, no M3-musca-
rinic receptor was detected in immunoprecipitates from CG
neurons prepared from M3-muscarinic receptor knock-out
mice (Fig. 1A).
Glutamate increased muscarinic receptor phosphorylation
by 2.21  0.25-fold (n  5) over basal and NMDA by 2.55 
0.33-fold [n  5] (Fig. 1B). This response appears to be medi-
ated via NMDA receptors because neither AMPA nor kainate
had any significant effect onM3-muscarinic receptor phospho-
rylation (Fig. 1C).
Whereas addition of the muscarinic receptor antagonist
atropine was able to completely block the phosphorylation
mediated by direct activation of the M3-muscarinic receptor
using the muscarinic agonist methacholine (Fig. 1B), atropine
had no effect on the NMDA- or glutamate-mediated phospho-
rylation (data not shown). Furthermore, combined stimulation
with NMDA and methacholine did not enhance the M3-mus-
carinic receptor phosphorylation over that induced by the ago-
nists individually (data not shown).
A role of NMDA receptors was confirmed by use of the
NMDA receptor-specific antagonistsMK-801 andAP-5, which
were able to block NMDA-mediated phosphorylation of the
M3-muscarinic receptor (Fig. 1D). The NMDA showed a tran-
sient time course that reached amaximum at 5min followed by
a steady decrease to basal levels by 30 min (Fig. 1E).
CamKII Activity Is Required for the Phosphorylation of
M3-muscarinic Receptors by NMDA—NMDA receptor activa-
tion will result in an influx of extracellular calcium and the
subsequent activation of a number of calcium-dependent sig-
FIGURE 2. Extracellular calcium and CamKII activity is required for NMDA-mediated phosphorylation of M3-muscarinic receptors. CG neurons were
[32P]orthophosphate labeled incalciumcontainingmedium.A, cellsweresubsequentlywashedwithcalcium-containing(leftpanel)ornominallycalcium-free (right
panel)medium,andstimulated for5minwithNMDA(100M)ormethacholine (100M).B, phosphorylationof theM3-muscarinic receptor in response toNMDA(100
M, 5min) in thepresenceor absenceof inhibitors of CamKII, KN-93andKN-62, and the inactive analogue, KN-92 (10M).C andD, timecourseof the free intracellular
calcium concentration in response to transient stimulation bymethacholine or NMDA in the absence (C) or presence (D) of KN-62. The phosphorylation of M3-mus-
carinic receptorswasquantifiedandnormalizedtothebasalphosphorylationandpresentedasthemeanS.D.*, significantdifferencebetweenbasalandstimulated
samples (p 0.01). **, significant difference betweenbasal and stimulated samples (p 0.05). Calcium traces correspond to the changes in free intracellular calcium
in single CG neurons and represent the response of at least 20 cells in three different assays.
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nalingmolecules in particularCamKII (3, 4).We showhere that
the ability of NMDA receptors to stimulate the phosphoryla-
tion of M3-muscarinic receptors is dependent on the presence
of extracellular calcium in the medium (Fig. 2). Following
[32P]orthophosphate labeling, the cells were washed with
medium (CSS-25) containing calcium or with nominally calci-
um-free medium. A subsequent stimulation with NMDA
resulted in a robust phosphorylation of the M3-muscarinic
receptor only in cells that were incubated in calcium containing
medium (Fig. 2A). In contrast, phosphorylation of M3-musca-
rinic receptors in response to the muscarinic receptor agonist
methacholine was not affected by the absence of calcium in the
medium (Fig. 2A).
To investigate the role of CamKII in the NMDA-mediated
response CG neurons were pretreated with the selective
CamKII inhibitors KN-93 or KN-62. Both of these pharmaco-
logical inhibitors prevented NMDA-
mediatedmuscarinic receptor phos-
phorylation, whereas the inactive
analogue KN-92 had no effect (Fig.
2B). To control for the possibility
that the CamKII inhibitors were
working in an indirect manner by
affecting free intracellular calcium
concentrations, we measured the
rise in intracellular calcium follow-
ing NMDA treatment in the
absence or presence of KN-62. As
illustrated in Fig. 2 (C and D), the
CamKII inhibitor did not alter the
ability of NMDA to increase intra-
cellular free calcium.
These pharmacological studies
indicated that CamKII was involved
in phosphorylation of M3-musca-
rinic receptors in response to
NMDA-stimulation. To further test
this, we used siRNA duplexes
against the -isoform of CamKII,
which we found to be highly
expressed in mouse CG neurons
(supplemental Fig. S1). These
siRNA duplexes significantly de-
creased CamKII- by more than
70% but had no off target effects on
kinases that have previous been
shown to phosphorylate theGPCRs,
i.e. GRK2, GRK6 (Fig. 3). Under
conditions where CamKII- was
knocked down, NMDA-mediated
phosphorylation of the M3-musca-
rinic receptor was decreased by
45.6  8.1% (n  3  S.D.). These
results indicated that CamKII-,
acting downstream of the NMDA
receptor, either directly phospho-
rylates the M3-muscarinic receptor
or is on a kinase cascade that results
in the phosphorylation of the receptor.
CamKII Is Able to Directly Phosphorylate the Third Intracel-
lular Loop of the M3-muscarinic Receptor—The mouse
M3-muscarinic receptor contains a large third intracellular
loop with 33 serine and 20 threonine residues. This compares
with only three threonine and one serine in the short C-ter-
minal tail. For this reason, and for that fact that the sites for
agonist-regulated phosphorylation have previously been
shown to be in the third intracellular loop (29, 34, 35), it was
decided to test whether CamKII could phosphorylate the
third intracellular loop in vitro. These experiments demon-
strated that a bacterially expressed glutathione S-transferase
fusion protein containing the third intracellular loop of the
mouse M3-muscarinic receptor (Arg252–Thr491) was phos-
phorylated specifically in the receptor portion of the fusion
protein by CamKII (Fig. 4A).
FIGURE 3. siRNA knock-down of CamKII reduces NMDA-mediatedM3-muscarinic receptor phosphoryla-
tion.CGneuronsonday5of culturewere sham-transfected (NT) or transfectedwith scrambled siRNAduplexes
or siRNA directed against CamKII- (80 pmol). A, after a further 2 days the cells weremetabolically labeledwith
[32P]orthophosphate and stimulated with NMDA (100 M for 5 min). The cells were then solubilized, and
M3-muscarinic receptor was immunoprecipitated. The gel was transferred to nitrocellulose and exposed to
reveal the phosphorylated receptor, after which the membrane was processed by Western blot to determine
equal receptor loading. B, a small sample of the lysate from each condition was retained for Western blotting
for CamKII-, GRK-2, and GRK-6. Shown are the data from a typical experiment carried out at least three times.
The graphs represent the cumulative data (mean S.E.) of at least three experiments carried out in duplicate.
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Mass spectrometry analysis of tryptic and chymotryptic pep-
tides established that Ser322 (supplemental Fig. S2) and Ser350
(supplemental Fig. S3)were phosphorylated in vitrobyCamKII.
Furthermore, one of the residues, serine 384/385 or threonine
397, are also phosphorylated (supplemental Fig. S4). These
studies demonstrate that CamKII
can directly phosphorylate specific
sites on theM3-muscarinic receptor
in vitro. The data from these exper-
iments are summarized in Fig. 4B.
NMDA Receptor Stimulation
Desensitizes M3-muscarinic Recep-
tor Phosphoinositide Signaling but
DoesNotAffectMuscarinic Receptor
Internalization—Our laboratory and
others have shown a clear link
between the phosphorylation of
M3-muscarinic receptors and
receptor internalization (29, 36).
Here we tested whether stimulation
of M3-muscarinic receptor phos-
phorylation via NMDA receptors
was able to mediate receptor inter-
nalization in CG neurons. Despite
there being significant levels of
receptor phosphorylation at early
time points following NMDA stim-
ulation, there was no evidence of a
change in the cell surface expression
of M3-muscarinic receptors as
determined by radioligand binding
(Fig. 5). In contrast, stimulation of
the muscarinic receptors with the
muscarinic agonist methacholine
resulted in robust receptor internal-
ization (Fig. 5).
M3-muscarinic receptors are
coupled via Gq/11-proteins to the
activation of PLC, which catalyzes
the hydrolysis of the phospholipid
phosphoinositide 4,5-bisphosphate
(PIP2) to generate two second mes-
sengers; diacylglycerol and inositol 1,4,5-trisphosphate (IP3)
(37). It is possible to track the activation of this secondmessen-
ger cascade in individual neurons in real time by using a biosen-
sor consisting of the pleckstrin homology (PH) domain of
PLC1 fused to eGFP (38). This fusion protein (eGFP-PHPLC1)
has high affinity for PIP2, and therefore when expressed in CG,
neurons will locate to the inner leaflet of the plasmamembrane
(39). On hydrolysis of PIP2 the eGFP-PHPLC1 fusion protein
translocates from the plasmamembrane to the cytoplasm. This
is in response to a depletion ofmembrane PIP2 but also because
the PHdomain for PLC1 has an20-fold higher affinity for IP3
than for PIP2 (40). By monitoring the translocation of eGFP-
PHPLC 1 from the plasma membrane to the cytoplasm, it is pos-
sible therefore tomeasure the coupling of themuscarinic receptor
to the phosphoinositide signal transduction cascade (39).
In this study, stimulation of the CG neurons with methacho-
line evoked a rapid and substantial translocation of eGFP-
PHPLC1 to the cytosol. The level of the phosphoinositide
response (named S1) remained elevated for the length of the
stimulation (F/F0 1.81 0.12; n 20; Fig. 6A). The value of
S1 served as an internal standard. Following withdrawal of
FIGURE 4. In vitro phosphorylation the M3-muscarinic receptor within the third intracellular loop by
CamKII. A, bacterially expressed GST or GST-3iloop (containing the third intracellular loop of the mouse
M3-muscarinic receptor) were used in an in vitro phosphorylation using purified CamKII (200 ng). Shown is a
representative experiment where the gel is first stained with Coomassie Blue and then an autoradiograph
obtained. B, diagram representation of the CamKII phospho-acceptor sites Ser322 and Ser350 as determined by
LC-MS/MS (in red) and a peptide that is singularly phosphorylated at one of three sites; serines 384/385 and
threonine 397 (indicated in blue). (See supplemental Figs. S2–S4 for detailed traces.)
FIGURE 5.NMDA-mediated phosphorylation of theM3-muscarinic recep-
tor does not mediate receptor internalization. CG neurons were stimu-
lated with agonists (100 M) for the indicated times. Surface M3-muscarinic
receptor expression was then determined using the hydrophilic muscarinic
antagonist [3H] n-methyl scopolamine. The data represent the means S.D.
of three experiments carried out in duplicate.
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methacholine, the eGFP-PHPLC1
probe returned to the plasma mem-
brane within 2 min (Fig. 6A). The
cells subjected to a second stimula-
tion with 100Mmethacholine gave
rise to a phosphoinositide response
(named S2) of very similar shape and
amplitude (F/F0 1.73 0.10; n 12;
Student’s t test, p 0.05) to the first
(S1). However, when cells were
treated with 100 M NMDA for 5
min before the second stimulation
withmethacholine, the amplitude of
S2 was significantly reduced (F/F0
1.43 0.08 [n 18]; Fig. 6B). These
data demonstrate that NMDA
receptor stimulation was able to
desensitize the M3-muscarinic
receptor phosphoinositide response.
NMDA-mediated Desensitization
of the M3-muscarinic Receptor Is
Dependent on Extracellular Calcium
and Calcium/Calmodulin-dependent
Kinase II Activity—The ability of
NMDA to mediate desensitization
of the M3-muscarinic receptor
phosphoinositide response was
completely dependent on the pres-
ence of extracellular calcium in the
medium (Fig. 6C). Withdrawing
extracellular calcium for the period
of NMDA stimulation resulted in an
S2 response to methacholine, which
was not significantly different from
controls (Fig. 6C).
Inhibition of CamKII using KN-62
significantly inhibited the ability of
NMDA treatment to desensitize the
methacholine response (Fig. 6C).
Control experiments established that
KN-62 did not interfere nonspecifi-
cally with the muscarinic receptor
phosphoinositide response (data not
shown). Importantly, KN-62 had no
indirect affects on the ability of
NMDA receptors to mediate an
influx of extracellular calcium (Fig.
2,C andD). These data indicate that
the ability of NMDA to desensitize
the M3-muscarinic receptor phos-
phoinositide response is dependent
on extracellular calcium influx and
CamKII activity.
DISCUSSION
It is clear from a large number of studies that GPCRs can
influence the activity of NMDA receptors and in so doing reg-
ulate physiological responses such as LTP and LTD (6). The
current study extends these findings by demonstrating that
NMDA receptors can also feedback onto GPCR signaling.
Hence, there appears to be a reciprocal regulatory process
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where both receptor types are able to mediate cross-talk allow-
ing for fine tuning of the signaling mechanisms that ultimately
lead to physiological processes such as synaptic plasticity.
The M3-muscarinic receptor subtype is a “classical” Gq/11-
coupled receptor that has been shown to couple to PLC- iso-
types in CG neurons (41). Furthermore, muscarinic receptor
subtypes are among a group of GPCRs that are known to regu-
late NMDA function through a number of mechanisms (16,
24–27). Hence, CG neurons are an ideal native cell type to test
the possibility that NMDA receptors might cross-talk with
GPCRs. We have done this here by focusing on the post-trans-
lational modification and signaling properties of the M3-mus-
carinic receptor.
Our previous studies have determined that the M3-musca-
rinic receptor is phosphorylated in response to agonist occupa-
tion by a range of receptor-specific kinases that include mem-
bers of the well characterized G-protein-coupled receptor
kinase (GRK) family (29, 42) and also by protein kinases CK2
(29) and CK1 (34). In these studies we have found no evidence
for a role of calcium-regulated protein kinases in agonist-me-
diated phosphorylation of M3-muscarinic receptors (32, 43).
Confirmation of this fact is reported in the current study where
withdrawal of extracellular calcium from the medium had no
significant effect on the agonist-regulated phosphorylation of
the M3-muscarinic receptor in CG neurons. In contrast, we
show here that stimulation ofNMDA receptors results in phos-
phorylation of M3-muscarinic receptors in CG neurons via a
mechanism that is completely dependent on extracellular cal-
cium. This immediately suggested that the elevation of intra-
cellular calcium mediated via calcium entry through the
NMDA receptors was activating calcium-regulated protein
kinases responsible for M3-muscarinic receptor phosphoryla-
tion. CamKII is a well established downstream effector of cal-
cium entry through NMDA receptors (4). By the use of phar-
macological inhibitors and siRNA, we established here that
CamKII activity was necessary for NMDA-mediated phospho-
rylation of the M3-muscarinic receptor.
The data presented here does not, however, show conclu-
sively that CamKII directly phosphorylates the M3-muscarinic
receptor. The possibility that CamKII is on a protein kinase
cascade that results in receptor phosphorylation cannot be
eliminated.
Our previous work had determined that the M3-muscarinic
receptor is phosphorylated on different sites by different pro-
tein kinases and that this results in differential regulation of
receptor signaling (29). This is illustrated by the fact that
M3-muscarinic receptor internalization is mediated by GRK
phosphorylation (36), whereas phosphorylation by protein
kinase CK2 has no effect on receptor internalization but regu-
lates the ability of the receptor to signal to the Jun-kinase path-
way (29). In this regard it is interesting to observe in the current
study thatCamKII-dependent phosphorylation of theM3-mus-
carinic receptor in CG neurons does not mediate receptor
internalization. It is likely, therefore, that CamKII directs phos-
phorylation of the receptor on different sites from that of the
GRKs and that the signaling outcome of phosphorylation is
therefore different (44) Our mass spectrometry analysis dem-
onstrated that the third intracellular loop of theM3-muscarinic
receptor can act as a substrate for CamKII. Ongoingwork in the
laboratory is aimed at determining whether the sites of CamKII
are indeed distinct from that of established receptor kinases (i.e.
GRK2/6, CK1, and CK2).
To determine the functional significance of NMDA-medi-
ated phosphorylation of theM3-muscarinic receptor, we exam-
ined the coupling of the receptor to theGq/11/phosphoinositide
signaling pathway. Although it is possible to measure bulk IP3
production (45), this approach is not sufficiently sensitive for
reliable use in CG neurons. We therefore turned to measuring
the activation of the phosphoinositide signaling cascade via the
translocation of the PIP2/IP3 biosensor eGFP-PHPLC 1 (39). A
short pulse of NMDA was able to significantly desensitize the
M3-muscarinic receptor-mediated phosphoinositide response.
This was dependent both on extracellular calcium and CamKII
activity and as such mimicked characteristics of NMDA-medi-
ated receptor phosphorylation. It appears, therefore, that the
process of NMDA-mediated desensitization of the M3-musca-
rinic receptor response is a consequence of CamKII-dependent
phosphorylation of the receptor.
This study, coupledwith our previously publishedwork, sug-
gests a complex process of by which NMDA receptors can reg-
ulate the M3-muscarinic receptor phosphoinositide response
in CG neurons. Here we demonstrate that pre-exposure to
NMDA results in desensitization of the phosphoinositide
response, whereas our previous work showed that concomitant
NMDA/muscarinic receptor activation results in an enhance-
ment of phosphoinositide signaling (41). Both of these effects
are via calcium entry-mediated by the NMDA receptor. In
the pre-exposure experiments, calcium entry results in
CamKII activation and receptor phosphorylation, which
uncouples the receptor form Gq/11. If, however, the NMDA
receptor is simultaneously stimulated with the M3-musca-
rinic receptor, then the elevated intracellular calcium levels
will feed forward to sensitize PLC- and enhance the recep-
tor-mediated response in a process that allows for coinci-
dence detection (41, 46). Thus, the signaling outcome of the
interaction between NMDA and M3-muscarinic receptors is
dependent on the temporal pattern of NMDA and musca-
rinic receptor stimulation.
FIGURE 6. Effect of NMDA on theM3-muscarinic receptor phosphoinositide response is dependent on calcium entry and CamKII activity. CG neurons
were transfected with eGFP-PHPLC1 and grown for 7–9 days before being imaged on an inverted epifluorescencemicroscope. A, continuously perfused cells
were subjected to two stimulations with methacholine (100 M). Shown is the time course of eGFP-PHPLC translocation from the plasma membrane to the
cytoplasm in a representative single cell expressedas changes in the cytoplasmic F/F0 self-ratio (see “Experimental Procedures”). Shownalso are representative
fluorescent images of CGneurons stimulatedwithmethacholine (100M) for 0, 3, 15, 24, and 29min. B, sameasAbut including a 5-min stimulationwithNMDA
(100M)prior to the secondmethacholine stimulation. Shownare imagesof a cell at times0, 3, 15, 18, 24, and29min.C, theeffectsof theCamKII inhibitor KN-62
(10 M) added 10 min before NMDA or the effects of removal of extracellular calcium on the NMDA-mediated desensitization of the M3-muscarinic receptor
phosphoinositide response. Thedata are representative tracesof 12–18 cells taken from8–10 independent experiments. The insets represent themeansS.D.
of the S1 and S2 phosphoinositide responses. *, significant difference between S1 and S2 (p 0.01). **, significant difference between S1 and S2 (p 0.05).
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This complex relationship between the NMDA and musca-
rinic receptors in CG neurons is consistent with an emerging
understanding of the multilayered regulatory mechanisms that
control NMDA-mediated synaptic plasticity. The fact that neu-
ronal plasticity is itself a dynamically regulated process is now
acknowledged and described by some as metaplasticity or
“plasticity of plasticity” (6, 47). Signaling pathways regulated by
GPCRs have been identified as major players in regulating
NMDA receptor function and defining the subtle changes in
NMDAreceptor activity that determineswhether a threshold is
obtained that drives synaptic strengthening (LTP) or alterna-
tively the threshold associated with synaptic weakening (LTD)
is the one that is attained. Our identification, in this study, of a
further layer of interaction between GPCRs and NMDA recep-
tors reveals an additional regulatory mechanism that can be
recruited by neurons in fine tuning the signaling networks that
converge on synaptic plasticity.
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